First came the "edible billboard," which appeared last year during the holidays in New York's East Village loaded with cake treats. Then, in late January, came the national marketing campaign, with TV ...

First came the “edible billboard,” which appeared last year during the holidays in New York’s East Village loaded with cake treats. Then, in late January, came the national marketing campaign, with TV ...

Plenity is FDA approved as a "device," and is a $98-a-month weight loss treatment First came the "edible billboard," which appeared last year during the holidays in New York's East Village loaded with ...

Ro is taking bets on the weight loss industry with a $30 million prepaid order of diet pill Plenity. The New York-based company inked a deal with Plenity creator Gelesis in 2019 to offer the product ...

Digital health unicorn Ro is pushing deeper into weight management with a $30 million preorder of weight loss pill Plenity for its members. Plenity, an FDA-approved pill produced by Gelesis that ...

Building on the successful beta launch of its first product Plenity®, Gelesis aims to transform weight management. Gelesis developed a novel biomimetic therapeutic platform that has yielded Plenity ...

As Chief Nutrition Officer, Bauer will focus on educating healthcare professionals and offering nutrition counseling to Plenity members She has worked closely with Plenity since spring 2021 on ...

A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million people. Public CPSR shareholders will own 21% of the company after the ...

BOSTON--(BUSINESS WIRE)--Gelesis Holdings, Inc. (NYSE: GLS) (“Gelesis” or the “Company”), the maker of Plenity for weight management, today reported financial results for the third quarter of 2022.

First came the "edible billboard," which appeared last year during the holidays in New York's East Village loaded with cake treats. Then, in late January, came the national marketing campaign, with TV ...